AtTRA v1.0

• Research type

  Research Study

• Full title

  Attitudes to Technology supported Rheumatoid Arthritis care in patients and clinicians

• IRAS ID

  264690

• Contact name

  Frances Humby

• Contact email

  f.humby@qmul.ac.uk

• Sponsor organisation

  Queen Mary University of London

• Duration of Study in the UK

  0 years, 6 months, 0 days

• Research summary

  The aim of this work is to determine the opportunities and barriers for intelligent mobile technology to support Rheumatoid Arthritis Care, targeted at both patients and clinicians as end users. To this end, the study seeks to understand the day-to-day challenges of living with and managing Rheumatoid Arthritis, in order to design technology which meets the needs of the target users, and understand the expectations patients and clinicians hold for intelligent mobile technology. This understanding will be used in the short term to improve existing apps and in the longer term as a basis for how next generation mobile health technology could provide support for those directly involved in Rheumatoid Arthritis care.
  Potential opportunities for support of patients include:
  Helping patients improve quality of life
  Improving clinical outcomes by achieving tighter disease control
  Supporting patients’ clinical decision making
  Supporting patient-clinician communication
  Reducing the need for direct patient-clinician contact
  Patient-patient support
  Educating patients
  Supporting behavioural change / attitudes to the disease / disease acceptance

  This is a mixed methods study with four parallel arms: Patient questionnaire, Patient semi-structured interview; Clinician Questionnaire, Clinician semi-structured interview. Patients over the ago of 18 with a diagnosis of Rheumatoid Arthritis and clinicians specialising in Rheumatology >1 year will be eligible to participate. All patients will be recruited from the Rheumatology dept at Mile End Hospital. Clinicians will be recruited electronically, via contacts of a Rheumatology Clinical Research Fellow, and various local and national Rheumatology e-mailing lists. The study will take place over a period of 6 months.

• REC name

  London - Bloomsbury Research Ethics Committee

• REC reference

  19/LO/1345

• Date of REC Opinion

  13 Sep 2019

• REC opinion

  Further Information Favourable Opinion